A Study to Evaluate AP-101 in Familial and Sporadic Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis Intervention: Drug: AP-101 Sponsor: AL-S Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials